FACTANKER · measured, cited, anchored official records connected

PROTECT PHARMACEUTICAL Corp — Net Income by Fiscal Year

21 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/396ee297-6d08-4fac-a1da-1b2233c77dd6/serie/net-income

Fiscal yearNet IncomePeriodEvidence
FY 2017$-122.6k2017-01-01 – 2017-12-31evidence 0001493152-19-002214
FY 2016$-41.7k2016-01-01 – 2016-12-31evidence 0001551163-17-000043
FY 2015$-635.5k2015-01-01 – 2015-12-31evidence 0001551163-16-000347
FY 2014$458.1k2014-01-01 – 2014-12-31evidence 0001551163-15-000098
FY 2013$-12.9M1987-08-05 – 2014-03-31evidence 0001551163-14-000135
FY 2012$-12.9M1987-08-05 – 2013-03-31evidence 0001551163-13-000070
FY 2011$-12.5M1987-08-05 – 2012-03-31evidence 0001551163-13-000055
FY 2010$-7.0M2010-01-01 – 2010-12-31evidence 0001144204-11-046857
FY 2009$-2.1k2009-01-01 – 2009-12-31evidence 0001144204-11-046857
FY 2008$-1.6k2008-01-01 – 2008-12-31evidence 0001144204-11-046857
FY 2007$-150.0k2007-01-01 – 2007-12-31evidence 0001144204-11-046857
FY 2005$-1.5k2005-01-01 – 2005-12-31evidence 0001144204-11-046857
FY 1996$-12.3k1996-01-01 – 1996-12-31evidence 0001144204-11-046857
FY 1995$-605.1k1995-01-01 – 1995-12-31evidence 0001144204-11-046857
FY 1994$-301994-01-01 – 1994-12-31evidence 0001144204-11-046857
FY 1993$-301993-01-01 – 1993-12-31evidence 0001144204-11-046857
FY 1992$-301992-01-01 – 1992-12-31evidence 0001144204-11-046857
FY 1991$-301991-01-01 – 1991-12-31evidence 0001144204-11-046857
FY 1990$-301990-01-01 – 1990-12-31evidence 0001144204-11-046857
FY 1989$-301989-01-01 – 1989-12-31evidence 0001144204-11-046857
FY 1988$-3.7M1988-01-01 – 1988-12-31evidence 0001144204-11-046857
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

PROTECT PHARMACEUTICAL Corp — all facts · Operating Income